Call Options

19 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.18 - $0.86 $2,016 - $9,632
-11,200 Reduced 3.28%
330,300 $86,000
Q1 2022

May 16, 2022

SELL
$0.6 - $1.06 $131,760 - $232,776
-219,600 Reduced 39.14%
341,500 $208,000
Q4 2021

Feb 14, 2022

BUY
$0.85 - $1.4 $265,540 - $437,360
312,400 Added 125.61%
561,100 $505,000
Q3 2021

Nov 15, 2021

BUY
$1.33 - $1.77 $29,260 - $38,940
22,000 Added 9.7%
248,700 $331,000
Q2 2021

Aug 11, 2021

SELL
$1.41 - $1.94 $180,762 - $248,708
-128,200 Reduced 36.12%
226,700 $326,000
Q1 2021

May 17, 2021

SELL
$1.61 - $2.77 $128,639 - $221,323
-79,900 Reduced 18.38%
354,900 $639,000
Q4 2020

Feb 16, 2021

BUY
$1.55 - $2.24 $214,365 - $309,792
138,300 Added 46.64%
434,800 $761,000
Q3 2020

Nov 16, 2020

BUY
$1.91 - $3.08 $72,389 - $116,732
37,900 Added 14.66%
296,500 $578,000
Q2 2020

Aug 14, 2020

BUY
$1.97 - $3.98 $317,367 - $641,178
161,100 Added 165.23%
258,600 $714,000
Q1 2020

May 15, 2020

BUY
$1.17 - $3.0 $71,136 - $182,400
60,800 Added 165.67%
97,500 $293,000
Q4 2019

Feb 14, 2020

SELL
$1.16 - $1.42 $3,595 - $4,402
-3,100 Reduced 7.79%
36,700 $45,000
Q3 2019

Nov 14, 2019

SELL
$1.21 - $1.65 $164,318 - $224,070
-135,800 Reduced 77.33%
39,800 $53,000
Q2 2019

Aug 14, 2019

BUY
$1.39 - $2.03 $25,715 - $37,555
18,500 Added 11.78%
175,600 $295,000
Q1 2019

May 15, 2019

SELL
$1.39 - $1.71 $12,649 - $15,561
-9,100 Reduced 5.48%
157,100 $236,000
Q3 2018

Nov 14, 2018

SELL
$1.86 - $2.18 $181,536 - $212,768
-97,600 Reduced 37.0%
166,200 $349,000
Q2 2018

Aug 14, 2018

BUY
$1.76 - $2.79 $205,744 - $326,151
116,900 Added 79.58%
263,800 $520,000
Q1 2018

May 15, 2018

BUY
$1.34 - $2.03 $104,654 - $158,542
78,100 Added 113.52%
146,900 $269,000
Q4 2017

Feb 14, 2018

SELL
$1.65 - $2.45 $58,740 - $87,220
-35,600 Reduced 34.1%
68,800 $125,000
Q3 2017

Nov 14, 2017

BUY
$1.5 - $2.55 $156,600 - $266,220
104,400
104,400 $215,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.